Alterity Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATHE and other ETFs, options, and stocks.

About ATHE

Alterity Therapeutics Ltd. engages in the business of research and development of therapeutic drugs designed to treat neurodegenerative diseases, focusing on Parkinsonian and other movement disorders. Its lead candidate, ATH434, is an oral small molecule drug designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. 

CEO
David A. Stamler
CEODavid A. Stamler
Employees
11
Employees11
Headquarters
Melbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded
1997
Founded1997
Employees
11
Employees11

ATHE Key Statistics

Market cap
77.87M
Market cap77.87M
Price-Earnings ratio
-4.48
Price-Earnings ratio-4.48
Dividend yield
Dividend yield
Average volume
17.30K
Average volume17.30K
High today
$4.33
High today$4.33
Low today
$4.05
Low today$4.05
Open price
$4.15
Open price$4.15
Volume
22.07K
Volume22.07K
52 Week high
$5.89
52 Week high$5.89
52 Week low
$2.66
52 Week low$2.66

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.